Becker's Healthcare January 2, 2026
From Robert F. Kennedy Jr.’s confirmation as HHS secretary to the resignation of the FDA’s top drug regulator, HHS saw several leadership transitions in 2025.
Beyond leadership, HHS announced plans in April to lay off 10,000 full-time employees, with dismissal notices sent that month. However, 954 HHS employees who received layoff notices during the federal government shutdown in October and November were later reinstated.
The most recent leadership exit was Walter Koroshetz, MD, director of the National Institute for Neurological Disorders and Stroke, who will exit his role after the National Institutes of Health terminated his contract. He informed colleagues in a Dec. 26 email that his tenure could end Dec. 28, but he was later granted a four-week extension...







